German orthopaedic company Implantate to float
This article was originally published in Clinica
German company aap Implantate hopes to raise around $11 million when it floats on the German Neuer Markt on May 10, the first biomedical company on that stock exchange. The company, which manufactures orthopaedic products and instruments for the trauma and joint replacement markets, plans to use the funds to expand distribution and launch new products.
You may also be interested in...
Reforms to the US 180-day exclusivity incentive included in the Blocking Act that is part of the Lower Health Care Costs Act could cost the US healthcare system approximately $1.7bn, the AAM has warned.
Moderate growth at Bristol-Myers Squibb and Amgen moved the two companies into the top 10 pharma ranks, based on the most recent Scrip 100 rankings, while declining growth at Gilead and Teva moved those drug makers out.